MedCity News September 25, 2024
Tim Church

Though chronic disease treatment is rapidly expanding, balancing the latest medication with proven initiatives can help employers manage rising healthcare costs wherever you fall on the GLP-1 coverage spectrum.

Employer healthcare costs are expected to increase by 9% next year, with pricey pharmacy expenses such as GLP-1s being the main driver. Because GLP-1s have demonstrated clinically significant results in many chronic conditions beyond weight loss, I expect to see physicians beginning to prescribe them for additional indications, opening the door for coverage of conditions such as kidney disease, liver disease, heart disease, sleep apnea, and more.

Given this backdrop, it’s worthwhile for employers to dive into the benefits and costs of these medications — even if you don’t currently...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Employer
The Pandemic Proved That Remote Leadership Works
More than 65 Organizations Call on Workplaces to Provide Comprehensive Obesity Care Coverage
The state of AI: How organizations are rewiring to capture value
To reduce healthcare costs, address chronic conditions
Why Leaders Must Rethink Customer Experience Amid Continued AI Investment

Share This Article